Teratogenic risks from exposure to illicit drugs.

Area of Science:

• Reproductive toxicology
• Developmental toxicology
• Perinatal pharmacology

Background:

• Substance use is widespread in the US, particularly among women of reproductive age.
• Many women do not cease substance use until pregnancy is confirmed, leading to fetal exposure.
• Illicit drug exposure during critical fetal organogenesis poses significant risks.

Purpose of the Study:

• To review limitations in published research on fetal risks associated with illicit substance use.
• To present current human data on the fetal effects of specific illicit substances.
• To highlight challenges in associating maternal substance use with pregnancy outcomes.

Main Methods:

• Literature review of published investigations.
• Synthesis of current human data on fetal effects.
• Analysis of limitations in existing research methodologies.

Main Results:

• Published studies face significant limitations in establishing direct causal links between illicit drug use and adverse fetal outcomes.
• Current data indicate varying degrees of fetal risk depending on the specific illicit substance and exposure timing.
• Understanding the precise impact of illicit drugs on fetal development remains complex.

Conclusions:

• Accurate assessment of fetal risks from illicit substance use is hampered by methodological challenges.
• Further research is needed to clarify the specific teratogenic effects of various illicit drugs.
• Comprehensive understanding is crucial for effective prenatal care and intervention strategies for substance-using pregnant individuals.